Binding of ⁹⁹mTc Plasminogen on Fibrin

Summary

Binding of plasminogen to fibrin was studied in vitro and in vivo using ⁹⁹mTc Glu- and Lys-plasminogen.

Binding of Glu-plasminogen on the clot was not observed in vitro, and in vivo in the dog.

Conversely, the binding of Lys-plasminogen to fibrin displays a linear relationship to the concentration of Lys-plasminogen, up to doses exceeding equimolarity; thus suggesting the existence of several Lys-plasminogen binding sites on fibrin. Binding levels were identical, regardless of whether plasminogen was incubated in normal plasma or in plasma devoid of antiplasmin. In the dog, Lys-plasminogen bound specifically to the clot, however, clot sites could not be localized by scintigraphy in the dog or in man.

Keywords

⁹⁹mTc Glu- and Lys-plasminogen - Binding to fibrin

• References

• 1 Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980; 43: 77-89
• 2 Wallen P, Wiman B. Characterization of human plasminogen.I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations. Biochim Biophys Acta 1970; 221: 20-30
• 3 Wallen P, Wiman B. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. Biochim Biophys Acta 1972; 257: 122-134
• 4 Hedner U, Nilsson IM, Robertson B. Determination of plasminogen in clots and thrombi. Thromb Diath Haemorrh 1966; 16: 38-50
• 5 Gottlob R. Plasminogen and plasma plasmin inhibitors in arterial and venous thrombi of various ages. In: Davidson JF, Samama MM, Desnoyers PC. (ed) Progress in chemical fibrinolysis and thrombolysis. Raven Press; 1975. vol. 01. p. 23-35
• 6 Soria J, Soria C, Samama M. A plasminogen assay using a chromogenic synthetic substrate: results from clinical work and from studies of thrombolysis. In: Davidson JF, Rowan RM, Samama MM, and Desnoyers PC. (ed) Progress in chemical fibrinolysis and thrombolysis. Raven Press; 1978. vol. 3. p. 337-346
• 7 Thorsen S. Difference in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation-influence of w-aminocarboxylic acids. Biochim Biophys Acta 1975; 393: 55-65
• 8 Scully MF, Strachan CJL, Kakkar VV. Binding of iodinated proteins to forming and preformed thrombi. Biochemical Society transactions 1973; 1: 1204
• 9 Rakoczi I, Wiman B, Collen D. On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin. Biochim Biophys Acta 1978; 540: 295-300
• 10 Harwig SS, Harwig JF, Sherman LA, Coleman RE, Welch MJ. Radioiodinated plasminogen: an imaging agent for pre-existing thrombi. J Nucl Med 1976; 18: 42-45
• 11 Lormeau JC, Choay J, Goulay J, Sache E, Vairel EG. Purification et propriétés des plasminogènes extraits du placenta humain. Ann Pharm franç, 1976; 34: 287-296
• 12 Deutsch D, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 13 Roux F, Juhan I, de Laforte C, Paulin R. Marquage du plasminogène avec le technetium 99m et l’iode 123 pour la detection des thrombis déjà formés.. 18 éme Colloque de Médecine Nucléaire de Langue Française, Reims. 1977
• 14 Vairel E. Méthodes d’étude “in vitro” et “in vivo” des fibrinolytiques. Prod Pharm 1970; 25: 347-353
• 15 Cederholm Williams SA. The binding of plasminogen and plasmin to fibrin. Thromb Res 1977; 11: 421-423
• 16 Kakkar W, Sagar S, Lewis M. Treatment of deep-vein thrombosis with intermittent streptokinase and plasminogen infusion. Lancet 1975; 11: 674-676
• 17 Griguer P, Charbonnier B, Latour F, Fauchier JP, Brochier M. Plasminogen and moderate doses of urokinase in the treatment of acute pulmonary embolism. Angeiology 1979; 1: 1-12